N
Nuvation Bio Inc. (NUVB)
NYQ – Real Time Price. Currency in USD
6.34
-0.03 (-0.39%)
Market open: Aug 12, 2026, 1:49 PM EDT
6.41
+0.04 (0.63%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
6.34
-0.03 (-0.39%)
Market open: Aug 12, 2026, 1:49 PM EDT
6.41
+0.04 (0.63%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $416.3M significantly exceeds cash reserves ($258.6M), raising financial stability concerns
Total current assets $726.4M exceed Total current liabilities $86.8M, highlighting excellent liquidity
Debt-to-equity ratio (1.6) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-7.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$43.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.37 | 6.05 | 10 | |
| Quick ratio | 8.14 | 5.63 | 10 | |
| Debt to Equity | 1.64 | 0.30 | 4.0 | |
| Debt to Assets | 0.56 | 1.04 | 4.0 | |
| Interest coverage | -7.55 | -16.91 | 1.0 | |
| Weighted average score | 5.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 8M | 63M | 170M |
| Gross Profit | -484K | -222K | 112K | 52M | 148M |
| Operating Income | -120M | -100M | -168M | -213M | -138M |
| Net Income | -104M | -76M | -568M | -205M | -150M |
| EBITDA | -119M | -100M | -167M | -211M | -135M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 178.33 | 23.92 | 10 |
| Next quarter | 20.3 | 6.22 | 7.5 |
| Current year | 218.28 | 36.1 | 10 |
| Next year | 41.65 | 48.32 | 10 |
| Weighted average score | 9.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -61.92 | -1264.34 | -1899.99 | -960.83 | 1.0 |
| Y/Y | 555.64 | -6.49 | -5.87 | 10.62 | 4.8 |
| 3y average | 898.99 | -185.99 | -134.73 | -31.81 | 3.3 |
| 5y average | 938.99 | -137.28 | -105.34 | -44.6 | 3.3 |
| Weighted average score | 3.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |